News + Filings Transactions
All All (ex-4s) 10-K 10-Q 8-K 3,4,5 Proxy Prospectus Other
|
Grossman Adam S
|
Create: Alert |
All | News | Filings
Date Filed | Type | Description |
10/03/2023 |
4
| Grossman Adam S (President and CEO) has filed a Form 4 on ADMA BIOLOGICS, INC.
Txns:
| Paid exercise price by delivering 18,718 shares
@ $3.58, valued at
$67k
|
|
08/18/2023 |
4
| Grossman Adam S (President and CEO) has filed a Form 4 on ADMA BIOLOGICS, INC.
Txns:
| Sold 250,000 shares
@ $4.1534, valued at
$1M
|
|
08/18/2023 |
144/A
| Form 144/A - Report of proposed sale of securities: [Amend] |
08/17/2023 |
4
| Grossman Adam S (President and CEO) has filed a Form 4 on ADMA BIOLOGICS, INC.
Txns:
| Sold 510,469 shares
@ $4.5428, valued at
$2.3M
Paid exercise price by delivering 1,589,987 shares
@ $4.61, valued at
$7.3M
Sold 3 shares
@ $4.385, valued at
$13.2 Exercised 212,500 options to buy
@ $1.67, valued at
$354.9k
Exercised 277,131 options to buy
@ $2.35, valued at
$651.3k
Exercised 277,604 options to buy
@ $2.915, valued at
$809.2k
Exercised 400,000 options to buy
@ $3.22, valued at
$1.3M
Exercised 350,000 options to buy
@ $3.71, valued at
$1.3M
Exercised 583,224 options to buy
@ $3.66, valued at
$2.1M
|
|
08/14/2023 |
144
| Form 144 - Report of proposed sale of securities: |
07/05/2023 |
4
| Grossman Adam S (President and CEO) has filed a Form 4 on ADMA BIOLOGICS, INC.
Txns:
| Paid exercise price by delivering 20,051 shares
@ $3.69, valued at
$74k
|
|
04/04/2023 |
4
| Grossman Adam S (President and CEO) has filed a Form 4 on ADMA BIOLOGICS, INC.
Txns:
| Paid exercise price by delivering 17,853 shares
@ $3.31, valued at
$59.1k
|
|
03/08/2023 |
4
| Grossman Adam S (President and CEO) has filed a Form 4 on ADMA BIOLOGICS, INC.
Txns:
| Paid exercise price by delivering 4,018 shares
@ $3.42, valued at
$13.7k
Paid exercise price by delivering 14,412 shares
@ $3.42, valued at
$49.3k
Paid exercise price by delivering 7,507 shares
@ $3.55, valued at
$26.6k
Granted 573,695 shares
@ $0 Paid exercise price by delivering 23,607 shares
@ $3.4, valued at
$80.3k
Granted 1,147,385 options to buy
@ $3.35, valued at
$3.8M
|
|
01/06/2023 |
4
| Grossman Adam S (President and CEO) has filed a Form 4 on ADMA BIOLOGICS, INC.
Txns:
| Paid exercise price by delivering 166,867 shares
@ $3.87, valued at
$645.8k
|
|
12/09/2022 |
4
| Grossman Adam S (President and CEO) has filed a Form 4 on ADMA BIOLOGICS, INC.
Txns:
| Bought 14,983 shares
@ $2.86, valued at
$42.9k
Bought 14,982 shares
@ $2.86, valued at
$42.8k
|
|
10/04/2022 |
4
| Grossman Adam S (President and CEO) has filed a Form 4 on ADMA BIOLOGICS, INC.
Txns:
| Paid exercise price by delivering 101,315 shares
@ $2.43, valued at
$246.2k
|
|
05/13/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
03/25/2022 |
4
| Grossman Adam S (President and CEO) has filed a Form 4 on ADMA BIOLOGICS, INC.
Txns:
| Paid exercise price by delivering 50,539 shares
@ $1.46, valued at
$73.8k
|
|
03/09/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
10/26/2021 |
4
| Grossman Adam S (President and CEO) has filed a Form 4 on ADMA BIOLOGICS, INC.
Txns:
| Bought 100,000 shares
@ $1, valued at
$100k
Bought 250,000 shares
@ $1, valued at
$250k
|
|
10/01/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
03/01/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
08/12/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
03/03/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
02/11/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
05/21/2019 |
4
| Grossman Adam S (President and CEO) has filed a Form 4 on ADMA BIOLOGICS, INC.
Txns:
| Bought 5,000 shares
@ $4, valued at
$20k
Bought 25,000 shares
@ $4, valued at
$100k
|
|
01/25/2019 |
4
| Grossman Adam S (President and CEO) has filed a Form 4 on ADMA BIOLOGICS, INC.
Txns:
| Granted 400,000 options to buy
@ $3.22, valued at
$1.3M
|
|
06/11/2018 |
4
| Grossman Adam S (President and CEO) has filed a Form 4 on ADMA BIOLOGICS, INC.
Txns:
| Bought 20,921 shares
@ $4.78, valued at
$100k
Bought 52,301 shares
@ $4.78, valued at
$250k
|
|
02/13/2018 |
4
| Grossman Adam S (President and CEO) has filed a Form 4 on ADMA BIOLOGICS, INC.
Txns:
| Granted 350,000 options to buy
@ $3.71, valued at
$1.3M
|
|
11/13/2017 |
4
| Grossman Adam S (President and CEO) has filed a Form 4 on ADMA BIOLOGICS, INC.
Txns:
| Bought 485,000 shares
@ $2.15, valued at
$1M
|
|
07/17/2017 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
06/08/2017 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
02/16/2017 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
01/24/2017 |
SC 13D/A
| Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend] |
05/05/2016 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
10/23/2013 |
4
| Grossman Adam S (President & CEO) has filed a Form 4 on ADMA BIOLOGICS, INC.
Txns:
| Bought 23,529 shares
@ $8.5, valued at
$200k
|
|
02/23/2012 |
SC 13D
| Grossman Adam S reports a 14% stake in ADMA Biologics, Inc. |
02/15/2012 |
4
| Grossman Adam S (President & CEO) has filed a Form 4 on R&R ACQUISITION VI, INC
Txns:
| Granted 438,919 shares
@ $0 Granted 33,088 options to buy
@ $3.4, valued at
$112.5k
Granted 212,134 options to buy
@ $9.6, valued at
$2M
|
|
02/15/2012 |
3
| Grossman Adam S (President & CEO) has filed a Form 3 on R&R ACQUISITION VI, INC |
|
|